Telesis Bio Inc

-0.02 (-1.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)31.72M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.4 Million
Adjusted EPS-$0.30
See more estimates
10-Day MA$1.13
50-Day MA$1.29
200-Day MA$1.80
See more pivots

Telesis Bio Inc Stock, NASDAQ:TBIO

10431 Wateridge Circle, Suite 150, San Diego, California 92121-2993
United States of America
Phone: +1.858.228.4115
Number of Employees: 243


Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.